For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Yuli Xie

USPTO Granted Patents = 18 (Patent Applications = 20)

EPO Patents = 3 (Patent Applications = 22)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

New York, NY (US) (2014 - 2018)
Shanghai, CN (2014 - 2024)

Company Filing History:

Columbia University

Wigen Biomedicine Technology (shanghai) Co., Ltd.

Wigen Boimedicine Technology (shanghai) Co., Ltd.

4. 1 out of 378

Soochow University

Years Active: 2014-2025

Loading Chart...

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12479843 - Spiro ring-containing quinazoline compounds (2025-11-25),

2. 12391692 - Spiro ring-containing quinazoline compound (2025-08-19),

3. 12351582 - Aurora kinase inhibitors and uses thereof (2025-07-08),

4. 12275726 - Aurora kinase inhibitors and use thereof (2025-04-14),

5. 12122774 - Compounds as MYT1 inhibitors (2024-10-22),

6. 11993598 - Compounds for inhibiting EGFR kinase, preparation methods and uses thereof (2024-05-28),

7. 11319303 - Compound used as autophagy regulator, and preparation method therefor and uses thereof (2022-05-03),

8. 11286247 - Acryloyl-containing nuclear transport regulators and uses thereof (2022-03-29),

9. 11021457 - Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof (2021-06-01),

10. 10005732 - Potent non-urea inhibitors of soluble epoxide hydrolase (2018-06-26),

11. 9402826 - Neuronal pain pathway modulators (2016-08-02),

12. 9260391 - Hypoglycemic dihydropyridones (2016-02-16),

13. 9175285 - Potent non-urea inhibitors of soluble epdxide hydrolase (2015-11-03),

14. 9012471 - Glucose metabolism modulating compounds (2015-04-21),

15. 8846742 - Neuronal pain pathway modulators (2014-09-30),

Title: Yuli Xie: Pioneering Inventor Crafting a Brighter Tomorrow

Introduction: Yuli Xie, a visionary inventor based in Shanghai, CN, has captured the essence of innovation through his remarkable contributions in the field of technology. With a total of 13 patents under his name, Yuli Xie continues to redefine the landscape of inventions with his unwavering dedication to creating a better future.

Latest Patents: Yuli Xie's recent patents showcase his profound impact in the scientific community. His inventions include compounds designed to inhibit EGFR kinase, offering promising advancements in the treatment of tumors and related diseases. Additionally, his work on compounds as autophagy regulators signifies a significant breakthrough in the realm of autophagy modulation for potential therapeutic applications.

Career Highlights: Yuli Xie has left an indelible mark on the industry through his collaborative efforts and innovative spirit. Having worked with esteemed organizations such as Columbia University in the City of New York and Wigen Biomedicine Technology (Shanghai) Co., Ltd., he has harnessed his expertise to propel groundbreaking research and development initiatives.

Collaborations: Throughout his career, Yuli Xie has collaborated with notable peers such as Donald W Landry and Shi-Xian Deng, fostering a culture of knowledge exchange and collective innovation. These partnerships have been instrumental in shaping Yuli Xie's holistic approach to problem-solving and driving technological advancements.

Conclusion: Yuli Xie's relentless pursuit of innovation and his passion for pioneering groundbreaking solutions underscore his status as a true trailblazer in the world of inventions. His trajectory exemplifies the transformative power of creative thinking and steadfast determination in shaping a brighter tomorrow through technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…